| pubmed-article:11770264 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11770264 | lifeskim:mentions | umls-concept:C0360714 | lld:lifeskim |
| pubmed-article:11770264 | lifeskim:mentions | umls-concept:C0678226 | lld:lifeskim |
| pubmed-article:11770264 | pubmed:issue | 49 | lld:pubmed |
| pubmed-article:11770264 | pubmed:dateCreated | 2001-12-27 | lld:pubmed |
| pubmed-article:11770264 | pubmed:abstractText | Rhabdomyolysis is a rare but potentially fatal complication associated with the use of cholesterol synthesis inhibitors (statins). The complication can develop in susceptible patients and with the concomitant use of medications that impede the biodegradation of statins, for example, biotransformation via the cytochrome P450 system. This may result in the plasma and tissue concentrations of statins, and their active metabolites, increasing to levels that are toxic for striated muscle. Myopathy is present when plasma activity levels of creatinine kinase are raised to in excess of 10 times the upper limit of the normal value. Muscular complaints which may be indicative of myotoxicity and subsequent myopathy are present in 1-7% of statin users. Albeit to varying degrees, all statins can induce myotoxicity especially at high dosages. Rhabdomyolysis was clearly more prevalent under cerivastatin users than the users of other statins and was therefore recently withdrawn from the market. Statins should be withdrawn immediately if myopathy is suspected. Prompt withdrawal may prevent rhabdomyolysis. | lld:pubmed |
| pubmed-article:11770264 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11770264 | pubmed:language | dut | lld:pubmed |
| pubmed-article:11770264 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11770264 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11770264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11770264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11770264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11770264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11770264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11770264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11770264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11770264 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11770264 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11770264 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:11770264 | pubmed:issn | 0028-2162 | lld:pubmed |
| pubmed-article:11770264 | pubmed:author | pubmed-author:BangaJ DJD | lld:pubmed |
| pubmed-article:11770264 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11770264 | pubmed:day | 8 | lld:pubmed |
| pubmed-article:11770264 | pubmed:volume | 145 | lld:pubmed |
| pubmed-article:11770264 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11770264 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11770264 | pubmed:pagination | 2371-6 | lld:pubmed |
| pubmed-article:11770264 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:11770264 | pubmed:meshHeading | pubmed-meshheading:11770264... | lld:pubmed |
| pubmed-article:11770264 | pubmed:meshHeading | pubmed-meshheading:11770264... | lld:pubmed |
| pubmed-article:11770264 | pubmed:meshHeading | pubmed-meshheading:11770264... | lld:pubmed |
| pubmed-article:11770264 | pubmed:meshHeading | pubmed-meshheading:11770264... | lld:pubmed |
| pubmed-article:11770264 | pubmed:meshHeading | pubmed-meshheading:11770264... | lld:pubmed |
| pubmed-article:11770264 | pubmed:meshHeading | pubmed-meshheading:11770264... | lld:pubmed |
| pubmed-article:11770264 | pubmed:meshHeading | pubmed-meshheading:11770264... | lld:pubmed |
| pubmed-article:11770264 | pubmed:meshHeading | pubmed-meshheading:11770264... | lld:pubmed |
| pubmed-article:11770264 | pubmed:meshHeading | pubmed-meshheading:11770264... | lld:pubmed |
| pubmed-article:11770264 | pubmed:meshHeading | pubmed-meshheading:11770264... | lld:pubmed |
| pubmed-article:11770264 | pubmed:meshHeading | pubmed-meshheading:11770264... | lld:pubmed |
| pubmed-article:11770264 | pubmed:meshHeading | pubmed-meshheading:11770264... | lld:pubmed |
| pubmed-article:11770264 | pubmed:meshHeading | pubmed-meshheading:11770264... | lld:pubmed |
| pubmed-article:11770264 | pubmed:meshHeading | pubmed-meshheading:11770264... | lld:pubmed |
| pubmed-article:11770264 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11770264 | pubmed:articleTitle | [Myotoxicity and rhabdomyolisis due to statins]. | lld:pubmed |
| pubmed-article:11770264 | pubmed:affiliation | Universitair Medisch Centrum Utrecht, afd. Interne Geneeskunde, Postbus 85.500, 3508 GA Utrecht. j.d.banga@azu.nl | lld:pubmed |
| pubmed-article:11770264 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11770264 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:11770264 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11770264 | lld:pubmed |
